BalonH.R., Fink-BennettD., StofferS.S.: Technetium-99m-SestaMIBI uptake by recurrent Hürtle cell carcinoma of the thyroid. J. Nucl. Med.33: 1393–1395, 1992.
2.
CanerB., KitapciM., UnluM., ErbengiG., CalkogluT., GoguS.T., BekdikC.: Technetium-99m-MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99m-MDP. J. Nucl. Med.33: 319–324, 1992.
3.
ChiuM.L., KronaugeJ.F., and Piwnica-WormsD.: Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile)-technetium(I) in cultured mouse fibroblasts. J. Nucl. Med.31: 1646–1653, 1990.
4.
MoingeonDelmon, Piwnica-WormsD., Van den AbbeeleA.D., HolmanB.L., DavisonA., JonesA.G.: Uptake of the cation hexakis (2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res.50: 2198–2202, 1990.
5.
KhalkhaliI., MenaI., JouanneE., DigglesL., AlleK., KleinS.: Tc-99m-SestaMIBI prone breast imaging in patients with suspicion of breast cancer. J. Nucl. Med.34: 140 p (suppl.), 1993.
6.
LeBouthellierG., TailleferR., LambertR., BavariaG., DuranceauA., LafontaineE., PellerinM., LéveilléJ.: Detection of primary lung cancer with Tc-99m-SestaMIBI. J. Nucl. Med.34: 140p (suppl.), 1993.
7.
MaffioliL., GaspariniM., GramagliaA., CastellaniM.R., VillaS., GiorgiC., ChitiA., BuraggiG.L.: Detection of brain tumor recurrences with Tc-99m MIBI SPECT. J. Nucl. Biol. Med.38: 255–256, 1994.
8.
O'DriscollC.M., BakerF., CaseyM.J., DuffeyG.J.: Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxyisobutylnitrile scintigraphy: a case report. J. Nucl. Med.32: 2281–2283, 1991.
9.
TuamaL.M., PackardA.B., TrevesS.T.: SPECT imaging of pediatric brain tumor with hexakis (methoxyisobutylisonitrile)-technetium (I). J. Nucl. Med.31: 2040–2041, 1990.
10.
Piwnica-WormsD., HolmanB.L.: Editorial: noncardiac applications of hexakis-(alkylisonitrile) technetium-99m complexes. J. Nucl. Med.31: 1166–1167, 1990.
11.
Piwnica-WormsD., KronaugeJ.F., ChiuM.L.: Uptake and retention of hexakis (2-methoxyisobutylisonitrile)-technetium(I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential-dependence. Circulation82: 1826–1838, 1990.
12.
ScottA.M., KostacogluL., O'BrienJ.P., StrausD.J., Abdel-DajemH.M., LarsonS.M.: Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary lymphoma. J. Nucl. Med.33: 1396–1398, 1992.
13.
WackersF.J., BermanD.S., MaddahiJ., WatsonD.D., BellerG.A., StraussH.W., BoucherC.A., PicardM., HolmanB.L., FridrickR., IngleseE., DelaloyeB., Bischof-DelaloyeA., CaminL., McKusickK.: Technetium-99m-hexakis-2-methoxyisobutylisonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J. Nucl. Med.30: 301–311, 1989.
14.
WestD.J., NajimY.C., MistryR., ClarkeS.E., FogelammI., MaiseyM.N.: The localization of myocardial ischaemia with technetium-99m-methoxyisobutylisonitrile and single photon emission computed tomography. Br. J. Radiol.62: 303–313, 1989.
